anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.07.21 | AstraZeneca Buy | UBS AG | |
| 13.07.21 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 13.07.21 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 12.07.21 | Vodafone Group Buy | UBS AG | |
| 12.07.21 | GSK Buy | Jefferies & Company Inc. | |
| 12.07.21 | Diageo Overweight | Barclays Capital | |
| 12.07.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 09.07.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 09.07.21 | Vodafone Group Buy | Kepler Cheuvreux | |
| 09.07.21 | Vodafone Group Overweight | Morgan Stanley | |
| 09.07.21 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 09.07.21 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 08.07.21 | Unilever Underweight | Morgan Stanley | |
| 08.07.21 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 08.07.21 | Rio Tinto Outperform | Credit Suisse Group | |
| 08.07.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 07.07.21 | HSBC Neutral | UBS AG | |
| 07.07.21 | Barclays Buy | UBS AG | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 07.07.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 07.07.21 | HSBC Buy | Goldman Sachs Group Inc. | |
| 06.07.21 | Barclays Buy | Goldman Sachs Group Inc. | |
| 07.07.21 | GSK Neutral | UBS AG | |
| 07.07.21 | GSK Equal-weight | Morgan Stanley | |
| 06.07.21 | BP Overweight | JP Morgan Chase & Co. | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 05.07.21 | Diageo Buy | Jefferies & Company Inc. | |
| 05.07.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.07.21 | Rio Tinto Equal Weight | Barclays Capital | |
| 02.07.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.07.21 | BAT Outperform | RBC Capital Markets | |
| 02.07.21 | Barclays Outperform | Credit Suisse Group | |
| 01.07.21 | GSK Neutral | UBS AG | |
| 01.07.21 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 30.06.21 | Prudential Neutral | JP Morgan Chase & Co. | |
| 30.06.21 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 30.06.21 | Unilever Neutral | JP Morgan Chase & Co. |